Share on Pinterest

Researchers have been examining other potential health benefits from GLP-1 agonist medications outside of type 2 diabetes management and weight loss.

Recent studies have found that GLP-1 medications may be linked to a decreased risk for certain cancers, including colorectal cancer.

A new study found GLP-1 medications may help lower mortality risk for people who have colon cancer, a type of colorectal cancer.

As glucagon-like peptide-1 (GLP-1) agonist medications have been gaining in popularity, researchers have been examining other potential health benefits from these drugs outside of type 2 diabetes management and weight loss .

For example, recent studies have found that GLP-1 medications may be linked to improved heart health , kidney health , and b

See Full Page